PROF

Profound Medical Corp.

10.19 USD

Last updated Dec 11, 22:28 UTC

Yesterday HIGH

$10.57

Yesterday LOW

$10.01

52w HIGH

$15.49

52w LOW

$5

EPS

-0.26

PE

-39.19

Next Earnings

Mar 5, 2024

Overview News Government Trades

Profound Medical Corp. stock is up 14.49% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 7 December’s closed higher than November. 0% of analysts rate it a buy.

Profound Medical Corp. develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Medical Equipment

Headquarters

-

Website

profoundmedical.com

Benzinga Insights

Mon Mar 6, 2023

Earnings Preview For Profound Medical
Benzinga Newsdesk

Fri Nov 4, 2022

Raymond James Upgrades Profound Medical to Strong Buy

Raymond James analyst Rahul Sarugaser upgrades Profound Medical (NASDAQ:PROF) from Outperform to Strong Buy.
Benzinga Newsdesk

Thu Nov 3, 2022

Profound Medical Q3 EPS $(0.24) Beats $(0.38) Estimate, Sales $2.04M Miss $2.35M Estimate
Benzinga Insights

Thu Nov 3, 2022

Earnings Scheduled For November 3, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Benzinga Insights

Fri Oct 21, 2022

Stocks That Hit 52-Week Lows On Friday

On Friday morning, 446 companies hit new 52-week lows.
Benzinga Insights

Wed Oct 19, 2022

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 200 companies hit new 52-week lows.
Benzinga Insights

Tue Oct 11, 2022

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 838 companies hit new 52-week lows.
Benzinga Insights

Mon Oct 10, 2022

Stocks That Hit 52-Week Lows On Monday

During Monday's trading, 528 companies set new 52-week lows.
Benzinga Insights

Wed Oct 5, 2022

Stocks That Hit 52-Week Lows On Wednesday

Wednesday saw 127 companies set new 52-week lows.
Bill Haddad

Mon Sep 26, 2022

Profound Medical Highlights Four Year Follow-Up Data From TACT Pivotal Clinical Trial

TORONTO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets